Worldwide, breast cancer comprises 22.9% of all non-melanoma skin cancers and 13.7% of 39 cancer deaths in women (1). Some of the primary risk factors for female breast cancer 40 include age (2), lack of childbearing or breastfeeding (3), high hormone levels (e.g. estrogen) 41 (4) and ethnicity (5). However, diet is another important factor that contributes to the 42 development of breast cancer (6) (7) (8) . The impact of diet on the incidence of breast cancer is 43 indicated by geographic differences in the occurrence of the disease (9), and by the many 44 dietary components experimentally proven to act as anti-breast cancer agents. One such 45 dietary factors is diallyl disulphide (DADS), which is a major (~60%) organosulfur 46 compound found in garlic oil (10). DADS inhibits the growth of breast cancer cell lines 47 (MDA-MB-231, KPL-1, MKL-F and MCF-7) (11) and reduces the incidence of N-methyl-N-48 nitrosourea (MNU) and 2-amino-1-methyl-6-phenylimidazo-4-5-b-pyridine (PhIP)-induced 49 mammary tumours (12, 13). The anti-cancerous effect of DADS is often attributed to its 50 ability to induce apoptosis in cancer cells via cell-cycle arrest and modulation of the activity 51 of Bcl-2 family proteins (14-16). 52
The difference between normal and cancerous cells is that the later lack the ability to die. In 53 normal tissue, a balance between cell proliferation and cell death must be maintained, 54 otherwise cells display uncontrolled growth and thereby cancer arises (17). Cellular apoptosis 55 or programmed cell death is the key process in maintaining this balance. Apoptosis naturally 56 occurs in mammalian tissues and is regulated by a cascade of cellular proteins, such as pro-57 and anti-apoptotic molecules. Prominent among such factors are the Bcl-2 family proteins 58 which act as signalling molecules in cellular apoptosis and survival pathways. Bcl-2 family 59 proteins include both pro-apoptotic (Bax, Bak, Bok, Bad, Bid, Bim and Bmf) and anti-60 apoptotic members (Bcl-2, Bcl-xL, Bcl-w, Mcl-1 and Bfl-1/A1) (18, 19) . Such pro-apoptotic 61 increased cellular levels of pro-apoptotic BAX and BAD, but decreased Bcl-2 levels (23). In 76 a similar study by Arunkumar et al. (2007) , the apoptotic impact of DADS in PC-3 cells were 77 accompanied by histone (H3 and H4) hyper acetylation (24). 78
Aberrant gene transcription is common in malignant cells, resulting in activation of some 79 genes and silencing of others (25, 26) . Such changes in transcriptional status are often 80 correlated with alterations in histone acetylation with hyper-acetylation mediating activation 81 whilst de-acetylation promotes gene silencing (27, 28 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 with phosphate buffered saline (PBS). Cells were then fixed by pipetting 1 ml of cell 114
suspension (approximately 10 6 cells/ml) was on to 4 ml of absolute ethanol at -20 °C in a 115
Falcon tube while vortexing at top speed. Fixed cells were re-hydrated in 5 ml PBS for 15 116 min at room temperature (RT). Finally, 3 mM propidium iodide (PI) in staining buffer (100 117 mM Tris; pH 7.4, 150 mM NaCl, 1 mM CaCl2, 0.5 mM MgCl2, 0.1% NP-40) was added and 118 mixed by gentle pipetting. Pancreatic RNAase (50 µl of 10 µg/ml stock; Sigma) was added 119 and the cells were incubated for 2 h at 4 °C. Cell cycle analysis was performed using a 120
FACScan Flow Cytometer (Becton Dickson) according to the manufacturer's protocol. 121
Annexin V/PI test 122
MCF-7 cells were tested for apoptosis induction by DADS using Annexin V-FITC/PI double 123 staining. Briefly, approximately 10 6 cells were washed in cold PBS followed by two washes 124 in binding buffer (10 mM HEPES, 140 mM NaCl, 2.5 mM CaCl 2 , 5 mM KCl, 1 mM MgCl 2 , 125 pH 7.4). Cells were then re-suspended in 100 µl Annexin V-FITC (4 µg/ml in binding buffer) 126
and incubated on ice for 10 min. An additional 400 ml of binding buffer, containing PI 127 (2 µg/ml), were added and the cellular suspension was incubated on ice for a further 15 min. 128
Cells thus treated were then analysed by flow cytometry. 129
Caspase-3 activation 130
MCF-7 cells were seeded in 96-well plates at a density of 10 5 cells/well. Plates were then 131 incubated overnight at 37˚C in a '5% CO 2 /95% humidity' atmosphere. DADS was added at 132 final concentrations of 1, 10 and 100 µM and cells were incubated for an additional 24 h. For 133 [EGTA], 0.5% NP-40; pH 7.5), and kept on ice for 15 min. The suspension was then 177 carefully pipetted over a 4 ml layer of sucrose buffer (30% sucrose, 10 mM Tris-HCl, 10 mM 178 NaCl, 3 mM MgCl 2 , pH 7.5), and centrifuged at 1300 xg and 4 °C for 10 min. The pellet was 179 resuspended in Tris-HCl buffer (10 mM Tris-HCl, 10 mM NaCl, pH 7.5) and centrifuged at 180 1300 xg, 4 °C for 10 min. The pellet (nuclear fraction) was re-suspended in extraction buffer 181 (50 mM HEPES, 420 mM NaCl, 0.5 mM EDTA, 0.1 mM EGTA, 10% glycerol, pH 7.5) and 182 
Statistical Analysis 191
All data were obtained from three independent experiments, and all results are expressed as 192 mean±SE. We employed the two-tailed (or paired) Student's t-test, using Microsoft Excel, to 193 determine significant differences. In all analysis, differences with probability values ≤ 0.05 194 were considered significant. 195 196 197 Results 198
DADS induce cell-cycle arrest and apoptosis in MCF-7 cells 199
Cell-cycle analysis of MCF-7 cells treated with 0-100 µM DADS showed that such treatment 200 causes changes in the occupation of the various stages of the cell cycle ( coupled with more than a tenfold increase (from 3.16 to 31.1%; p ≤ 0.05) in the number of 206 apoptotic, sub-G 0 cells (Fig. 1) . In contrast, the G 0 /G 1 and G 2 /M populations were little 207 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 (Fig. 1) . The DADS induction of apoptosis was confirmed by Annexin 208 V/PI double staining which detects both early and late apoptotic cells (AV and PI stained 209 cells, respectively). Annexin V binds to phosphatidylserine (PS) translocated from the inner 210 leaflet of the plasma membrane (considered a hallmark of early apoptosis (45) (Fig. 2) . Thus, the double-staining analysis indicates that 100 µM DADS 216 increased total apoptotic cell numbers by more than threefold from 18.2 to 59.7% (p ≤ 0.05) 217 (Fig. 2) , a result which closely matches that obtained by single labeling (Fig. 1) . 218
DADS increases caspase-3 activity in MCF-7 cells 219
In order to determine whether activation of caspase-3 might be involved in the observed 220 DADS-induced apoptosis of MCF-7 cells, such cells were tested for caspase-3 activity 221 following DADS treatment, by fluorescence assay. The results show that caspase-3 activity 222 increased by 80.8% ± 24.9 and 270% ± 13.6 in cells treated with 10 and 100 µM DADS, 223 respectively, compared to untreated cells (Fig. 3) . Indeed, the caspase-3 induction achieved 224
by the highest dose of DADS (370%) was close to that obtained by staurosporine (500%) (the 225 positive control). However, low concentrations (1 µM) of DADS had no significant impact 226 on caspase-3 activation. 'Caspase-3 inhibitor' eliminated the effects of DADS on caspase-3 227 activity indicating that the increases in activity observed in the absence of inhibitor were 228 indeed caspase-3 specific (Fig. 3) . These results show that DADS elicits a dose-dependent 229 stimulation of caspase-3 activity in MCF-7 cells (Fig. 3) which suggests that caspase-3 230 activation is a component of the DADS-dependent induction of apoptosis in MCF-7 cells. 231 7.83, respectively, by treatment with 10 and 100 µM DADS, although levels were not notably 237 affected by DADS at 1 µM (Fig. 4) . In contrast, DADS failed to significantly increase the 238 levels of either Bak or Bid in MCF-7 cells (Fig. 4) . However, all three of the anti-apoptotic 239
Bcl-2 proteins examined here were reduced by DADS treatment: 10 and 100 µM DADS 240 decreased Bcl-2 cellular levels by 42.2% ± 9.13 and 64.4% ± 9.7; Bcl-xL cellular levels were 241 decreased by 33.3% ± 8.7 and 57.7% ± 7.7; and Bcl-w cellular levels were decreased by 242 38.1% ± 8.4 and 68.6% ± 7.4, respectively (Fig. 4) . Thus, DADS at 10-100 µM raises the 243 MCF-7 cellular levels of at least one pro-apoptotic Bcl-2 family protein (Bax) and decreases 244 those of at least three anti-apoptotic Bcl-2 proteins (Bcl-2, Bcl-xL and Bcl-w). These effects 245 are again fully consistent with the DADS-induced apoptosis reported above, and roles for 246
Bcl-2 proteins in modulating DADS-stimulated apoptosis in MCF-7 cells. 247
248

DADS induces H 4 acetylation and inhibits the deacetylation activity of MCF-7 nuclear 249 extract 250
The above studies show that the apoptosis effect generated by DADS in MCF-7 cells 251 correlates with appropriate changes in the levels Bcl-2 family proteins. Previous work 252
suggests that such changes in protein levels may arise from alterations in expression caused 253 by modifications of histone acetylation status (46, 47) . To determine whether the effects of 254 DADS might arise through alterations in histone acetylation, global changes in overall 255 histone acetylation levels were assayed using TAU gel electrophoresis (Fig.5 I) . This analysis 256
showed that histone 4 is primarily in the unacetylated and mono-acetylated forms in untreated 257 MCF-7 cells. However, following treatment with 1 µM DADS, the di-acetylated form of 258 histone 4 became apparent as a minor species. As the DADS concentrations were raised more 259 so, the acetylation profiles were further altered as tri-and tetra-acetylated histone 4 became 260 increasingly apparent (Fig. 5I) . Thus, DADS treatment raises the histone-4 acetylation status 261 of MCF-7 nuclear DNA. 262
To determine whether the increased histone acetylation levels are caused by DADS-mediated 263 inhibition of deacetylase activity, the effect of DADS on the ability of MCF-7 nuclear 264 extracts to remove acetyl groups from an acetylated substrate was investigated (Fig.5 II) . The 265 addition of DADS, at 10 and 100 µM, to MCF-7 nuclear extracts diminished deacetylation 266 activities to 85.7% ± 17.6 and 64.2% ± 12.9 of that of controls, although 1 µM DADS had no 267 significant effect. TSA, a potent deacetylases inhibitor (39), reduced deacetylation to 24.77% 268 ± 7.6 of that of the control, showing that the assay was effective in reporting deacetylation 269 inhibition. The results therefore suggest that the DADS-induced increase in acetylation of 270 histone 4 is caused by the ability of DADS to act as a direct HDAC inibitor. 271
Discussion 272
The health benefits and medicinal properties of garlic have long been known. Records dating 273 back to 1550 BC describe garlic as a "wonder drug" for a variety of diseases (48). 274
Epidemiological studies report that high consumption of garlic decreases the risk of breast 275 cancer (49, 50). This effect has been attributed to DADS, which is present in garlic cloves at 276 ~140 mM as the major organosulfur compound of garlic oil (51), since it inhibits the growth 277 of breast cancer cells in vitro through induction of apoptosis (14, 16 It should be stressed that human studies on garlic consumption and cancer risk provide 283 limited evidence of any relationship between garlic intake and protection against cancer (55-284 58). However, the value of such human studies is often limited by variability in the garlic 285 preparations taken and uncertainty concerning the amounts of garlic consumed (58), and it is 286 suggested that further human trials are required in order to establish whether dietary garlic 287 exhibits any anti-cancerous effects (59). Important factors affecting DADS availability in 288 food include alkalinity and processing, which highlights the need to consider various aspects 289 of diet, as well as the composition of the garlic, when assessing any health benefit of garlic in 290 clinical trials (60-63). Although the direct exposure of human breast cancer cells to DADS 291 (as performed here) fails to replicate the complexity of the whole human system, such studies 292 have the advantage of avoiding the problems raised above that are associated with diet 293 composition effects. 294
The studies reported here confirm that DADS is able to induce apoptosis in the breast cancer 295 cell line, MCF-7, by interfering with the cell cycle. DADS increased the sub-G 0 , apoptotic 296 population in a dose-dependent manner and at the same time decreased the occupancy of the 297 S phase of the cycle, indicating an inhibition of DNA synthesis had occurred. These findings 298 are consistent with those reported previously (11, 16, (64) (65) (66) (67) where the growth inhibitory 299 properties of DADS were also attributed to its induction of apoptosis and reduction in DNA 300 synthesis in KPL-1, MCF-7, COLO 205, HCT-116 and B16F-10 cells. Examination of both 301 early (e.g. PS translocation) and late (e.g. caspase-3 activation) molecular events 302 characteristic of apoptosis confirmed the ability of DADS, at physiologically relevant 303 concentration (10-100 µM), to induce apoptosis in MCF-7 cells. 304 factor' (AIF), from the mitochondrial inter-membrane space into the cytosol (20, 68) . 307
Released cytochrome c binds to cytosolic Apaf-1 to form the 'apoptosome' in a reaction that 308 eventually leads to the autoactivation of pro-caspase-9 (69) which in turn activates the 309 effector caspases (-3, -6 and -7) leading to apoptosis (70). Released AIF is translocated to the 310 nucleus where it induces DNA fragmentation (71). The balance between the levels of pro-311 and anti-apoptotic proteins within the cell is crucial in determining whether apoptosis 312 progresses (72). The involvement of Bcl-2 family proteins in DADS-induced apoptosis in 313 MCF-7 cells was suggested (Fig. 4) HDACi have the ability to suppress cancer growth and induce apoptosis in vitro in cancer cell 324 cultures and in vivo in tumor bearing animal models (73-76). In this study, it was shown that 325 DADS has HDACi properties when presented at relatively low concentrations (10-100 µM) 326 that are likely to be well within dietary concentrations ranges (51). Low concentrations of 327 DADS were found to inhibit the removal of the acetyl group from an acetylated substrate 328 through reducing the HDAC enzymatic activity of MCF-7 nuclear extracts by up to 35.8%. 329 factors, such as the pro-and anti-apoptotic Bcl-2 family proteins as observed here. However, 342 the precise mechanism by which Bcl-2 family protein expression is modulated and apoptosis 343 is induced by DADS remains unclear. Similar effects were obtained when a renal tubular cell 344 line (RPTC) was treated with a histone deacetylase inhibitor (suberoylanilide hydroxamic 345 acid). This caused a decrease in Bcl-xL levels, while the expression levels of Bax and Bak 346 remained relatively constant (81). It is unlikely that all of the expression changes observed 347 here are a direct effect of histone acetylation status, since levels of Bcl-2, Bcl-xL and Bcl-w 348 were decreased (rather than increased) by DADS. Thus, further work is required to decipher 349 the precise manner in which DADS promotes apoptosis in MCF-7 breast cancer cells. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  P  e  e  r  R  e  v  i  e  w  O  n  l  y 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
